View on market: Stay Cautious, be with quality business:

Asian shares opened mixed Monday and U.S. equity futures dipped after stocks ended the week at all-time highs, with investors focusing on the economic recovery and upcoming earnings. Japan’s benchmark edged lower, while Australia and South Korea were in the green after the S&P 500 Index capped its fourth straight weekly advance. The Singapore-traded SGX Nifty, an early indicator of the Nifty 50 Index’s performance in India, down 1.14% to 14,458, as of 8:08 a.m.

Key Data/ Action, Result and Board meeting to watch

Major economic Data:

  • INR: Deposit Growth on 23rd April, 2021
  • INR: Bank Loan Growth on 23rd April, 2021

Non-Nifty Results: ACC, Bajaj Consumer, CRISIL, ICICI Prudentia

HDFC Bank Q4FY21 Result:

Net profit up 18.17% at Rs 8,186.51 crore versus Rs 6,927.7 crore (Bloomberg Estimate: Rs 8,436 crore) NII up 12.6% at Rs 17,120 crore versus Rs 15,204 crore (Bloomberg Estimate: Rs 16,408.9 crore) GNPA at 1.32% versus 0.81% (QoQ) NNPA at 0.4% versus 0.09% (QoQ) Q3FY21 proforma GNPA: 1.38%, NNPA: 0.4% Approved one-time restructuring schemes for loans worth Rs 6,508.37 crore Floating provisions at  Rs 5,861 crore Deposits up 16.3% at Rs 13.35 lakh crore Term deposits up 8.5% at Rs 7.19 lakh crore.

International Markets:

U.S & Europe

Particulars    16th Apr. Chg Chg(%)
Nasdaq 14052.34 13.58 0.1
Dow 34200.67 164.68 0.48
FTSE 7019.53 36.03 0.52
CAC 6287.07 52.93 0.85
DAX 15459.75 204.42 1.34
Dow Fut.* 33,996.00 -84 -0.25


Asian markets:

Particulars    19th Apr. Chg Chg(%)
SGX Nifty 14458.20 -166 -1.14
Nikkei 29744.62 61.25 0.21
Straits Times 3206 4.24 0.13
Hang Seng 29081.71 112 0.39
Shanghai 3446.54 19.92 0.58


ADR Watch:

Particulars       16th Apr. Chg Chg(%)
Dr Reddy 65.01 0.88 1.37
HDFC Bank 71.81 0.3 0.42
ICICI Bank 15.22 -0.13 -0.85
Infosys 18.18 0.18 1
Tata Motor 20.51 0.34 1.69
Wipro 6.96 0.4 6.1

Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 74.35     -0.76
Brent 66.44 -0.49
Gold 1,776.65     -0.20
Silver 25.87     -0.91



Particulars   16th Apr.       15th Apr.
FIIs 437.51       979.70
DIIs     657.55    -526.63


News Update:

Glenmark Pharmaceuticals:

The wholly-owned subsidiary of the company, Glenmark Life Sciences, has filed a draft red herring prospectus with the SEBI for an initial public offer. The offer comprises a fresh issue of up to Rs 1,160 crore and an offer for sale of up to 73.05 lakh shares of Rs 2 each of Glenmark Life Sciences, by Glenmark Pharmaceutical. The IPO will be subject to market conditions, receipt of applicable approvals and other consideration.

Kolte-Patil Developers:

Collections rose 16.8% year-on-year at Rs 442 crore in the March quarter. Sales volume gained 27.1% YoY at 0.85 million sq. ft. Sales value up 42.7% YoY at Rs 511 crore. The Q4 FY21 collections are the highest-ever in the company’s three-decade history. A strong focus on sales, registrations, construction and CRM has enabled strong recovery in collections. Further, the company has signed three new projects with a combined saleable area of 2.2 MSF in Pune under capital-light models.

Bharti Airtel:

The Government of Ghana, Millicom International Cellular S.A. and Bharti Airtel have executed the definitive agreement for the transfer of ‘AirtelTigo’ to the Government of Ghana on a going concern basis. In the proposed agreement, the Government of Ghana will acquire 100% shares of AirtelTigo along with all customers, assets and liabilities. Airtel had already written off its investment and provided for it in the prior accounts. No further provisions of any material nature are envisaged.

Coal India:

Incorporated two wholly-owned subsidiaries, viz. CIL Solar PV for manufacturing of solar value chain and CIL Navikarniya Urja for renewable energy.


To issue unsecured non-convertible bonds of Rs 3,996 crore on April 20 through a private placement at a coupon of 6.87% per annum. The bonds will mature on April 21, 2036. The proceeds from the issue will be utilised for funding of capital expenditure, refinancing of existing loans and other general corporate purposes. The bonds are proposed to be listed on NSE.

Adani Green:

Says unit wins bid for 150mw solar power project at INR2.22/KWH for 25 years; to be commissioned by 3Q FY23

Grindwell Norton:

SG Shinagawa Refractories India, a joint venture between Shinagawa Refractories, Japan, and Grindwell Norton, has commenced its commercial operation of tap hole clay refractory products for the steel industry.

ISGEC Heavy Engineering:

Signed a project-specific collaboration pact with United Conveyor Corp., USA, for Dry Sorbent Injection technology.


Non-banking finance companies (NBFCs) have requested the Reserve Bank to extend the one-time restructuring scheme of MSME advances till March 31, 2022, as these players are unable to revive their businesses.


Q4FY21 Revenue up 4.23% at Rs 2,109.3 crore versus Rs 2,023.7 crore (Bloomberg estimate: Rs 2,096.8 crore) Net profit down 2.82% at Rs 317.3 versus Rs 326.5 crore (Bloomberg estimate: 303.8 crore) Ebit down 1.24% at Rs 391.3 crore versus Rs 396.2 crore (Bloomberg estimate: Rs 380.7 crore) Ebit Margin at 18.60% Versus 19.60% (Bloomberg Estimate: 18.15%).

  Source: Moneycontrol, Livemint, Business Standard, Bloomberg, Investing


Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report. For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy
of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators.
For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of an y company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale. Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011- 22795783 and Website:
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one %. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of publicappearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerag e services from the subject companyin the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerageservices from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. 3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory